Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/KINTOR-PHARMACEUTICAL-LIM-111325374/news/Kintor-Pharmaceutical-Limited-Announces-China-NMPA-Approves-Clinical-Trial-of-ALK-1-and-Nivolumab-Co-36650132/?utm_source=whatsapp&utm_medium=social&utm_campaign=share